TBT BSN | Notification

Notification Detail :: G/TBT/N/USA/2062

Notification No.

Notification Type

Notifying Member

Date of Notification

Final Date for Comments

Days to Final Date

Title

Trichloroethylene (TCE); Regulation Under the Toxic Substances 
Control Act (TSCA)

Objective

Protection of the environment (TBT); Protection of human health or safety (TBT)

Product Covered

Trichloroethylene; Environmental protection (ICS code(s): 13.020); Production in the chemical industry (ICS code(s): 71.020); Products of the chemical industry (ICS code(s): 71.100)

Document Notification

Link to ePing

HSCODE

ICSCODE

13.020 - Environmental protection; 71.020 - Production in the chemical industry; 71.100 - Products of the chemical industry

Keywords

Specific Regions

Description

Proposed rule - The Environmental Protection Agency (EPA) is proposing to 
address the unreasonable risk of injury to human health presented by 
trichloroethylene (TCE) under its conditions of use as documented in 
EPA's November 2020 Risk Evaluation for TCE and January 2023 revised 
risk determination for TCE pursuant to the Toxic Substances Control Act 
(TSCA). TCE is widely used as a solvent in a variety of industrial, 
commercial and consumer applications including for hydrofluorocarbon 
(HFC) production, vapor and aerosol degreasing, and in lubricants, 
greases, adhesives, and sealants. TSCA requires that when EPA 
determines a chemical substance presents unreasonable risk that EPA 
address by rule the unreasonable risk of injury to health or the 
environment and apply requirements to the extent necessary so the 
chemical no longer presents unreasonable risk. EPA determined that TCE 
presents an unreasonable risk of injury to health due to the 
significant adverse health effects associated with exposure to TCE, 
including non-cancer effects (liver toxicity, kidney toxicity, 
neurotoxicity, immunotoxicity, reproductive toxicity, and developmental 
toxicity) as well as cancer (liver, kidney, and non-Hodgkin lymphoma) 
from chronic inhalation and dermal exposures to TCE. TCE is a 
neurotoxicant and is carcinogenic to humans by all routes of exposure. 
The most sensitive adverse effects of TCE exposure are non-cancer 
effects (developmental toxicity and immunosuppression) for acute 
exposures and developmental toxicity and autoimmunity for chronic 
exposures. To address the identified unreasonable risk, EPA is 
proposing to: prohibit all manufacture (including import), processing, 
and distribution in commerce of TCE and industrial and commercial use 
of TCE for all uses, with longer compliance timeframes and workplace 
controls for certain processing and industrial and commercial uses 
(including proposed phaseouts and time-limited exemptions); prohibit 
the disposal of TCE to industrial pre-treatment, industrial treatment, 
or publicly owned treatment works, with a time-limited exemption for 
cleanup projects; and establish recordkeeping and downstream 
notification requirements.

Notified Document

1:File here

Link to Notification

EN:File here

FR:File here

ES:File here

Status Active

No	#	Comment By	Title	Comment Date	File

Back

Notification Detail :: G/TBT/N/USA/2062

Link to ePing

App Settings